IMCR vs TT · rev $222.6M vs P/E 36, rev $11.32B
Immunocore Holdings Ltd (IMCR) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Immunocore Holdings Ltd (IMCR) is a biotechnology company listed on NASDAQ.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported IMCR revenue for 2026-06-30 was $222.6M. Net income was $12.2M. IMCR currently screens at market cap $1.45B.
Latest reported TT revenue for 2026-06-30 was $11.32B. Net income was $1.51B. TT currently screens at market cap $104.45B and trailing P/E 36.2.
IMCR currently screens at market cap $1.45B. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the IMCR and TT stock pages for the full models.
Not investment advice.